Telehealth vs In-Person Palliative Care for Lung Cancer

(REACH PC Trial)

Recruiting at 22 trial locations

Overseen By Jennifer Temel, MD

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: Massachusetts General Hospital

Disqualifiers: Receiving outpatient PC, hospice, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

1250 Participants Needed

Trial Summary

What is the purpose of this trial?

This research study is evaluating ways to provide palliative care to patients who have recently been diagnosed with lung cancer and their families.

Research Team

Jennifer Temel, MD

Principal Investigator

Massachusetts General Hospital

Eligibility Criteria

This trial is for adults over 18 with advanced non-small cell lung cancer, treated without the aim of cure and informed about their condition within the last 12 weeks. They must be able to communicate in English or Spanish, live where the care team is licensed, and have a close contact involved. Excluded are those already in outpatient palliative care or hospice, or with cognitive/psychiatric conditions affecting consent.

Inclusion Criteria

I can take care of myself but may spend more than half the day in bed due to my condition.

I am 18 years old or older.

I can read and answer questions in English or Spanish.

Exclusion Criteria

You have mental health conditions that make it difficult for you to understand and participate in the study.

I am currently getting palliative care or hospice services as an outpatient.

Treatment Details

Interventions

• In-person PC
• Telehealth

Trial Overview The study compares two ways of delivering palliative care: through telehealth services versus traditional in-person visits. It aims to determine which method better supports patients recently diagnosed with lung cancer and their families.

Participant Groups

Group I: Telehealth Experimental Treatment 1 Intervention

* Patients will meet with the PC clinician in person within four weeks of enrollment * Subsequent visits with the PC clinician will be conducted with the patients in their home or other location using video at least every four weeks * Patients may be scheduled to meet with the PC clinician in the clinic if requested by the patient or a clinician

Group II: In Person PC Active Control 1 Intervention

* Patients will be scheduled for their first In-person PC visit within four weeks of enrollment and then at least every four weeks thereafter until the patient is no longer coming into the clinic * PC visits will be scheduled on the same day as an oncology visit if possible

Who Is Running the Clinical Trial?

Massachusetts General Hospital

Lead Sponsor

Trials

3,066

Recruited

13,430,000+

Palliative Care Research Cooperative Group

Collaborator

Trials

9

Recruited

2,200+

Patient-Centered Outcomes Research Institute

Collaborator

Trials

592

Recruited

27,110,000+